These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 31364326)

  • 1. New foot-and-mouth disease vaccine, O JC-R, induce complete protection to pigs against SEA topotype viruses occurred in South Korea, 2014-2015.
    Jo HE; Ko MK; Choi JH; Shin SH; Jo H; You SH; Lee MJ; Kim SM; Kim B; Park JH
    J Vet Sci; 2019 Jul; 20(4):e42. PubMed ID: 31364326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved foot-and-mouth disease vaccine, O TWN-R, protects pigs against SEA topotype virus occurred in South Korea.
    Choi JH; Ko MK; Shin SH; You SH; Jo HE; Jo H; Lee MJ; Kim SM; Lee JS; Kim B; Park JH
    Vet Microbiol; 2019 Sep; 236():108374. PubMed ID: 31500734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved foot-and-mouth disease vaccine with O PanAsia-2 strain protect pigs against O/Jincheon/SKR/2014 originated from South Korea.
    Ko MK; Jo HE; Choi JH; You SH; Shin SH; Jo H; Lee MJ; Kim SM; Kim B; Park JH
    Vaccine; 2020 Jan; 38(5):1120-1128. PubMed ID: 31810782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-protective efficacy of engineering serotype A foot-and-mouth disease virus vaccine against the two pandemic strains in swine.
    Zheng H; Lian K; Yang F; Jin Y; Zhu Z; Guo J; Cao W; Liu H; He J; Zhang K; Li D; Liu X
    Vaccine; 2015 Oct; 33(43):5772-5778. PubMed ID: 26431990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cross-protection against three topotypes of serotype O foot-and-mouth disease virus in pigs vaccinated with multi-epitope protein vaccine incorporated with poly(I:C).
    Cao Y; Lu Z; Li D; Fan P; Sun P; Bao H; Fu Y; Li P; Bai X; Chen Y; Xie B; Liu Z
    Vet Microbiol; 2014 Jan; 168(2-4):294-301. PubMed ID: 24345411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of type O foot-and-mouth disease by vaccination in Korea, 2014-2015.
    Park JH; Tark D; Lee KN; Chun JE; Lee HS; Ko YJ; Kye SJ; Kim YJ; Oem JK; Ryoo S; Lim SB; Lee SY; Choi JH; Ko MK; You SH; Lee MH; Kim B
    J Vet Sci; 2018 Mar; 19(2):271-279. PubMed ID: 29169228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a high quality O
    Galdo Novo S; Malirat V; Maradei ED; Pedemonte AR; Espinoza AM; Smitsaart E; Lee KN; Park JH; Bergmann IE
    Vaccine; 2018 Mar; 36(12):1570-1576. PubMed ID: 29472132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of vaccine strains for serotype O foot-and-mouth disease viruses (2007-2012) circulating in Southeast Asia, East Asia and Far East.
    Mahapatra M; Upadhyaya S; Aviso S; Babu A; Hutchings G; Parida S
    Vaccine; 2017 Dec; 35(51):7147-7153. PubMed ID: 29157957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Basis of Antigenic Drift in Serotype O Foot-and-Mouth Disease Viruses (2013-2018) from Southeast Asia.
    Upadhyaya S; Mahapatra M; Mioulet V; Parida S
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swine.
    Fernandez-Sainz I; Medina GN; Ramirez-Medina E; Koster MJ; Grubman MJ; de Los Santos T
    Virology; 2017 Feb; 502():123-132. PubMed ID: 28039799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection to homologous and heterologous challenge in pigs immunized with vaccine against foot-and-mouth disease type O caused an epidemic in East Asia during 2010/2011.
    Park JN; Lee SY; Chu JQ; Lee YJ; Kim RH; Lee KN; Kim SM; Tark DS; Kim B; Park JH
    Vaccine; 2014 Apr; 32(16):1882-9. PubMed ID: 24525017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics.
    Li P; Bai X; Sun P; Li D; Lu Z; Cao Y; Fu Y; Bao H; Chen Y; Xie B; Liu Z
    BMC Vet Res; 2012 May; 8():57. PubMed ID: 22591597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient protection against Asia1 type foot-and-mouth disease using a chimeric vaccine strain suitable for East Asia.
    Ko MK; Jo HE; Choi JH; You SH; Shin SH; Hwang SY; Jo H; Kim HM; Lee MJ; Kim SM; Kim B; Park JH
    Vet Microbiol; 2021 Feb; 253():108975. PubMed ID: 33418393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A foot-and-mouth disease SAT2 vaccine protects swine against experimental challenge with a homologous virus strain, irrespective of mild pathogenicity in this species.
    Mouton L; Dekker A; Bleijenberg M; Blanchet M; Coco-Martin J; Hudelet P; Goutebroze S
    Vaccine; 2018 Apr; 36(15):2020-2024. PubMed ID: 29510916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of optimal age for single vaccination of growing pigs with foot-and-mouth disease bivalent vaccine in South Korea.
    Kim AY; Tark D; Kim H; Kim JS; Lee JM; Kwon M; Bae S; Kim B; Ko YJ
    J Vet Med Sci; 2017 Nov; 79(11):1822-1825. PubMed ID: 28943596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of novel inactivated vaccines for the SAT 1, SAT 2 and SAT 3 serotypes of foot-and-mouth disease in pigs.
    Jo HE; You SH; Choi JH; Ko MK; Shin SH; Song J; Jo H; Lee MJ; Kim SM; Kim B; Park JH
    Virol J; 2019 Dec; 16(1):156. PubMed ID: 31842907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric vaccine strain of type O foot-and-mouth disease elicits a strong immune response in pigs against ME-SA and SEA topotypes.
    Ko MK; Jo HE; Choi JH; You SH; Shin SH; Jo H; Lee MJ; Kim SM; Kim B; Park JH
    Vet Microbiol; 2019 Feb; 229():124-129. PubMed ID: 30642587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine strain of O/ME-SA/Ind-2001e of foot-and-mouth disease virus provides high immunogenicity and broad antigenic coverage.
    Lee G; Hwang JH; Park JH; Lee MJ; Kim B; Kim SM
    Antiviral Res; 2020 Oct; 182():104920. PubMed ID: 32828822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with a FMDV O Mya98 lineage virus in pigs 4 and 7 days post vaccination.
    Wilna V; Hong NT; Geoffrey FT; Jacqueline MM; Jianning W; Van Phuc K; Ngon QV; Phuong le TT; Hung D; Hanh TX; Van Hung V; Anh le TQ; Tien MT; Quang le TV; Long NT; Nagendrakumar SB
    Vaccine; 2015 Jun; 33(24):2778-85. PubMed ID: 25917677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of germanium biotite supplement on immune responses of vaccinated mini-pigs to foot-and-mouth disease virus challenge.
    Jung M; Park HT; Park JH; Lee KN; Shin SW; Shin MK; Sung KY; Jung YK; Kim B; Yoo HS
    Immunol Invest; 2015; 44(1):101-12. PubMed ID: 25058651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.